The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
None of the observations are related to data integrity and management believes that they are addressable
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
Subscribe To Our Newsletter & Stay Updated
